Author

Kalil Saab

Baylor College of MedicineORCID 0009-0005-2066-2700Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kalil Saab1 paper · Baylor College of Medicine

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Abdullah A. OsmaniD· 1 shared Chandrashekar R. AmbatiiD· 1 shared Cristian CoarfaiD· 1 shared Emerald Kan· 1 shared Faye M. JohnsoniD· 1 shared Fonma Essien· 1 shared Heath Devin SkinneriD· 1 shared Hussam Dayoub· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdullah A. OsmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBritish Journal of CancerPeer-reviewedOct 6, 2025

Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting

Pedram Yadollahi, Kelli A. McCord, Li Yang…·Vlad Constantin Sandulache

This paper identifies PI3K pathway activation in Nrf2-driven cisplatin-resistant HNSCC and shows that gedatolisib inhibits tumor growth and re-sensitizes cells to cisplatin.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky